Cargando…

Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma

BACKGROUND: Diabetes mellitus (DM) is identified as a negative prognostic indicator in hepatocellular carcinoma (HCC), though the basis for this is unknown. METHODS: This is a retrospective analysis of a prospectively collected database of 191 HCC patients treated at the University of Rochester Medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connolly, Gregory C, Safadjou, Saman, Kashyap, Randeep, Chen, Rui, Orloff, Mark S, Hezel, Aram F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562150/ https://www.ncbi.nlm.nih.gov/pubmed/23317091 http://dx.doi.org/10.1186/1471-230X-13-9

Ejemplares similares

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
por: Mohamed, Mostafa, et al.
Publicado: (2015)

Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Three Cases of Hepatocellular Carcinoma With Massive Macrovascular Invasion Successfully Treated With Radiotherapy
por: Tsurugai, Yuichiro, et al.
Publicado: (2021)

How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
por: Kim, Beom Kyung
Publicado: (2023)

Stereotactic Body Radiation Therapy as a Bridge to Transplantation and for Recurrent Disease in the Transplanted Liver of a Patient with Hepatocellular Carcinoma
por: Mazloom, Ali, et al.
Publicado: (2014)

Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma
por: Fu, Sirui, et al.
Publicado: (2021)

Multi-task deep learning network to predict future macrovascular invasion in hepatocellular carcinoma
por: Fu, Sirui, et al.
Publicado: (2021)

Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion
por: Chen, Wenhao, et al.
Publicado: (2021)

Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion
por: Niizeki, Takashi, et al.
Publicado: (2021)

Dynamic Nomogram for Predicting Macrovascular Invasion of Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yan, Huiwen, et al.
Publicado: (2022)

Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion
por: Zhao, Hui, et al.
Publicado: (2017)

Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases
por: Wu, Mengfei, et al.
Publicado: (2019)

Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion
por: Yang, Dan, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Effects of various interventions on the occurrence of macrovascular invasion of hepatocellular carcinoma after the baseline serum γ-glutamyltransferase stratification
por: Liu, Yao, et al.
Publicado: (2019)

Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion
por: Zhao, Yuting, et al.
Publicado: (2019)

Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection
por: Zhang, Yanfang, et al.
Publicado: (2022)

Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy
por: Ji, Mengling, et al.
Publicado: (2022)

Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib
por: Lu, Meng-Chuan, et al.
Publicado: (2023)

Treatment of specific macrovascular beds in patients with diabetes mellitus
por: Petznick, Allison M, et al.
Publicado: (2010)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chawla, Aastha, et al.
Publicado: (2016)

Cost of diabetes mellitus and related macrovascular complications in Turkiye
por: Birinci, Suayip, et al.
Publicado: (2023)

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients
por: Chen, Jinbin, et al.
Publicado: (2017)

Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy
por: Liang, Bin-yong, et al.
Publicado: (2021)

Comparison of External Beam Radiation Therapy Modalities for Hepatocellular Carcinoma With Macrovascular Invasion: A Meta-Analysis and Systematic Review
por: Wu, Guanheng, et al.
Publicado: (2022)

Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
por: Kim, Ji Hoon, et al.
Publicado: (2023)

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
por: Jin, Sujin, et al.
Publicado: (2023)

Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
por: Sano, Shusei, et al.
Publicado: (2019)

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
por: Ogasawara, Sadahisa, et al.
Publicado: (2022)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Comparison of macrovascular invasion-free survival in early-intermediate hepatocellular carcinoma after different interventions: A propensity score-based analysis
por: Liu, Yao, et al.
Publicado: (2019)

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
por: Tsai, Hong-Ming, et al.
Publicado: (2021)

Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion: Erratum
Publicado: (2015)

Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy
por: Chong, Huanhuan, et al.
Publicado: (2021)

Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients
por: Huang, Daniel Q., et al.
Publicado: (2022)

Segmental Distribution of Hepatocellular Carcinoma Correlates with Microvascular Invasion in Liver Explants Undergoing Transplantation
por: Al-Azzawi, Yasir, et al.
Publicado: (2019)

Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus
por: Wang, Shenqi, et al.
Publicado: (2013)

Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
por: Wu, Juei-Seng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3frjdlnr6cfiemjuovm89qsan